ReviewCritical reviews in oncology/hematology2021
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea.
Review in Critical reviews in oncology/hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Psychological consequences of the COVID-19 pandemic in people with type 1 diabetes: A systematic literature review.Journal of psychosomatic research · 2023Pooled it
- Spinal Surgery in National Emergencies: Lessons from a Pandemic Era of Postponed and Ultimately Cancelled Operations.Indian journal of orthopaedics · 2025Article
- Low Dose Cyclophospahamide is a Feasable Mobilization Regimen in the Covid-19 Era: A Single Center Study from Türkiye.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025Article
- Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- The impact of the Covid-19 pandemic on outpatient visits for patients with cancer in Iran: an interrupted time series analysis.Archives of public health = Archives belges de sante publique · 2025Article
- Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience.Frontiers in immunology · 2025Article
- Cancer management during the COVID-19 world pandemic.Cancer immunology, immunotherapy : CII · 2023Review
- Hepatopancreatobiliary malignancies: time to treatment matters.Journal of gastrointestinal oncology · 2023Article
- Spatial Optimization to Improve COVID-19 Vaccine Allocation.Vaccines · 2022Article
- Impact of the COVID-19 Pandemic on Melanoma Diagnosis in Romania-Data from Two University Centers.International journal of environmental research and public health · 2022Article
- Lung cancer surgical treatment during the pandemic: a challenging situation.Journal of thoracic disease · 2022Article
- Impact of COVID-19 Pandemic on Non-Melanoma Skin Cancer's Tumor Burden and Care: a Multi-Center Study Based in Northern Italy.Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2022Article
- Conceptual Framework for Cancer Care During a Pandemic Incorporating Evidence From the COVID-19 Pandemic.JCO global oncology · 2022Review
- Geospatial Perspectives on the Intersection of Chronic Disease and COVID-19.Preventing chronic disease · 2022Article
- Monitoring the impact of COVID-19 in France on cancer care: a differentiated impact.Scientific reports · 2022Article
- Impact of hospital strain on excess deaths during the COVID-19 pandemic-United States, july 2020-july 2021.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022Article
- Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic - United States, July 2020-July 2021.MMWR. Morbidity and mortality weekly report · 2021Article
- The effect of COVID-19 pandemic on daily oncology clinical practice.Critical reviews in oncology/hematology · 2021Article
- Treatment decision for cancer patients with fever during the coronavirus disease 2019 (COVID-19) pandemic.Yeungnam University journal of medicine · 2021Article
- Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 was declared a "Public Health Emergency of International Concern" in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical care. A delay in testing and treating cancer patients is thought to protect them from serious COVID-19 complications but exposes them at the same time to the risk of disease progression and cancer related mortality. Healthcare providers are therefore facing the dilemma of choosing between two unpleasant scenarios. To shed light upon the matter, we present in this review article, based on an extensive search of the literature, an overview of the delay in the management of cancer patients, possible contributors to this delay and its benefits and risks on cancer patients' health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.